Table 3.
Age‐adjusted | Model 1 | Model 2 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β | B | 95% CI (Low, High) | P value | β | B | 95% CI (Low, High) | P value | β | B | 95% CI (Low, High) | P value | |
FIB‐4 index | ||||||||||||
n = 415 | ||||||||||||
IGF‐1 | NA | NA | NA | NA | −0.32 | −0.007 | −0.009, −0.005 | <0.0001 | −0.29 | −0.006 | −0.009, −0.004 | <0.0001 |
IGF‐1 SDS | NA | NA | NA | NA | −0.22 | −0.17 | −0.24, −0.09 | <0.0001 | −0.22 | −0.17 | −0.25, −0.10 | <0.0001 |
IV‐7S | ||||||||||||
n = 176 | ||||||||||||
IGF‐1 | −0.40 | −0.009 | −0.01, −0.006 | <0.0001 | −0.24 | −0.006 | −0.009, −0.002 | 0.004 | −0.27 | −0.007 | −0.01, −0.003 | 0.0004 |
IGF‐1 SDS | −0.44 | −0.34 | −0.44, −0.24 | <0.0001 | −0.27 | −0.20 | −0.31, −0.09 | 0.0004 | −0.30 | −0.23 | −0.34, −0.13 | <0.0001 |
The 95% confidence intervals (CI) were expressed as (Low, High). Fibrosis‐4 (FIB‐4) index: model 1 was adjusted for the following factors: sex, body mass index (BMI), fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), visceral fat area (VFA), systolic blood pressure (SBP), triglyceride (TG), high‐density lipoprotein cholesterol (HDL‐C), gamma glutamyl transpeptidase (γ‐GTP) and growth hormone (GH). Model 2 was adjusted for factors that were found to be an independent variable in univariate analyses, such as BMI, FPG, HbA1c, VFA, TG, HDL‐C, γ‐GTP, glimepiride, glinides and statins. IV‐7S: Model 1 was adjusted for the following factors: age, sex, BMI, FPG, HbA1c, VFA, SBP, TG, HDL‐C, AST, ALT, γ‐GTP, platelets and GH. Model 2 was adjusted for factors that were found to be an independent variable in univariate analyses, such as age, VFA, AST, ALT, γ‐GTP and platelets. ALT, alanine aminotransferase; AST, aspartate aminotransferase; B, partial regression coefficient; IGF‐1, insulin‐like growth factor‐1; IV‐7S, 7S domain of type IV collagen.